Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549

23 Dec 2013

Abstract excerpt

Cancer stem cells (CSCs) are subpopulations of tumor cells that are responsible for tumor initiation, maintenance and metastasis. Recent studies suggested that lung cancer arises from CSCs. In this study, the expression of potential CSC markers in cell line A549 was evaluated. We applied flow cytometry to assess the expression of putative stem cell markers, including aldehyde dehydrogenase 1 (ALDH1), CD24, CD44,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24363164
DOI: 10.2478/s11658-013-0112-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549PMID 24363164Read ↗

Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.Semantic proximity Read ↗

Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cellsSemantic proximity Read ↗

Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like PropertiesSemantic proximity Read ↗

The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.Semantic proximity Read ↗

CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancerSemantic proximity Read ↗

Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterizationSemantic proximity Read ↗

Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer SubtypesSemantic proximity Read ↗

Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem CellsSemantic proximity Read ↗

Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell linesSemantic proximity Read ↗

Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis.Semantic proximity Read ↗

Cancer stem cells and cisplatin‐resistant cells isolated from non‐small‐lung cancer cell lines constitute related cell populationsSemantic proximity Read ↗

Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.